Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Some nutritional supplements may help treat hair loss with generally mild side effects.

Low-level light/laser therapy is effective in treating male and female pattern hair loss without side effects.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Topical minoxidil effectively treats Female Pattern Hair Loss in women of all ages and hormone levels, but evidence for antiandrogens is limited.

Combining two treatments for hair loss works better than using just one.

PCOS is a major cause of infertility in women of childbearing age.

Topical caffeine improves hair loss intensity, speed, and shedding, and works better with minoxidil/azelaic acid.

Patients with PCOS face poor communication and support from healthcare professionals.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Individualized treatment and psychological support are crucial for alopecia.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Minoxidil can treat female hair loss but may cause side effects.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Eruptive vellus hair cysts are a cosmetic skin condition, more common in young adults, with few effective treatments.

Selenium's effectiveness in treating Hashimoto's thyroiditis is inconclusive.

Topical corticosteroids are the best initial treatment for children with Alopecia Areata.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Certain foods and supplements can help treat skin diseases alongside medication.